Cargando…
Lack of TSH stimulation in patients with differentiated thyroid cancer – possible causes
Differentiated thyroid cancer is one of the most common endocrine cancers. Typical standard treatment includes total thyroidectomy with partial lymphadenectomy, then depending on the indications, treatment with iodine isotope 131-I. A prerequisite to conduct the therapy is to obtain endogenic thyroi...
Autores principales: | Gut, Paweł, Matysiak-Grześ, Magdalena, Fischbach, Jakub, Klimowicz, Aleksandra, Gryczyńska, Maria, Ruchała, Marek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687409/ https://www.ncbi.nlm.nih.gov/pubmed/23788893 http://dx.doi.org/10.5114/wo.2012.29299 |
Ejemplares similares
-
Peptide Receptor Radionuclide Therapy of Differentiated Thyroid Cancer: Efficacy and Toxicity
por: Czepczyński, Rafał, et al.
Publicado: (2014) -
Chromogranin A – unspecific neuroendocrine marker. Clinical utility and potential diagnostic pitfalls
por: Gut, Paweł, et al.
Publicado: (2016) -
Contemporary methods of therapy and follow-up of neuroendocrine tumours of the gastrointestinal tract and the pancreas
por: Gut, Paweł, et al.
Publicado: (2012) -
Clinical features of gastroenteropancreatic tumours
por: Gut, Paweł, et al.
Publicado: (2015) -
Does TSH Trigger the Anti-thyroid Autoimmune Processes? Observation on a Large Cohort of Naive Patients with Thyroid Hemiagenesis
por: Szczepanek-Parulska, Ewelina, et al.
Publicado: (2016)